Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Comparative Outcomes of Immunochemotherapy with RCD (rituximab, cyclophosphamide, dexamethasone) and BCD (bortezomib, cyclophosphamide, dexamethasone) in Waldenstrom Macroglobulinaemia: NCT02971982

Jingjing Shang, Lingzhi Yan, Jin Zhou, Song Jin, Chengcheng Fu, Depei Wu, MD, Ying Yao

Blood (2017) 130 (Supplement 1): 5166.

https://doi.org/10.1182/blood.V130.Suppl_1.5166.5166

Published: 2017

Journal Articles

RCHOP-21 Vs. RCHOP-14 for the Treatment of Newly Diagnosed Diffuse Large B Cell Lymphoma: A Prospective Randomized Phase III Clinical Trial from Cswog

Tongyu Lin, He Huang, Xueying Li, Chengcheng Guo, Huangming Hong, Xiaohong Fu, Xiaoting Lin, Xiaojie Fang, Zhao Wang, Zhongjun Xia, MD

Blood (2015) 126 (23): 2690.

https://doi.org/10.1182/blood.V126.23.2690.2690

Published: 2015

Journal Articles

Vasculitis Associated with Large Granular Lymphocytes Leukemia

Alexandra Audemard, MD student, Thierry Lamy, MD, PhD, Benoit Bareau, MD, Felipe Suarez, MD, PhD, Margaret Macro, MD, Loic Guillevin, MD, PhD, Flore Sicre, MD, Florence Truquet, Salaun Veronique, Jerome Rey, MD, Estibaliz Lazzaro, MD, PhD, Jonathan Boutemy, MD, Laurence Verneuil, MD, PhD, Stephane Cheze, Nicolas Schleinitz, MD, PhD, Thierry Lobbedez, MD, Loic Geffray, MD, Cindy Castrale, MD, Boris Bienvenu, MD, PhD

Blood (2012) 120 (21): 5109.

https://doi.org/10.1182/blood.V120.21.5109.5109

Published: 2012

Journal Articles

Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation and Failed to Achieve a Complete Response

Robert M. Rifkin, MD, Gary Spitzer, MD, Andrew Greenspan, MD, John F. Schwerkoske, MD, Romeo A. Mandanas, MD, FACP, Joe Stephenson, MD, George T. Kannarkat, Feng Zhan, PhD, Lina Asmar, PhD, Roy Beveridge, MD

Blood (2008) 112 (11): 2780.

https://doi.org/10.1182/blood.V112.11.2780.2780

Published: 2008

Journal Articles

Neurological Complications Following Allogeneic Haematopoietic Stem Cell Transplantation

Yamin Tan, He Huang, MD, PhD, Yi Luo, Jimin Shi, Zhen Cai, Maofang Lin

Blood (2008) 112 (11): 4307.

https://doi.org/10.1182/blood.V112.11.4307.4307

Published: 2008

NARROW

Comparative Outcomes of Immunochemotherapy with RCD (rituximab, cyclophosphamide, dexamethasone) and BCD (bortezomib, cyclophosphamide, dexamethasone) in Waldenstrom Macroglobulinaemia: NCT02971982

RCHOP-21 Vs. RCHOP-14 for the Treatment of Newly Diagnosed Diffuse Large B Cell Lymphoma: A Prospective Randomized Phase III Clinical Trial from Cswog

Vasculitis Associated with Large Granular Lymphocytes Leukemia

Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation and Failed to Achieve a Complete Response

Neurological Complications Following Allogeneic Haematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Comparative Outcomes of Immunochemotherapy with RCD (rituximab, cyclophosphamide, dexamethasone) and BCD (bortezomib, cyclophosphamide, dexamethasone) in Waldenstrom Macroglobulinaemia: NCT02971982

RCHOP-21 Vs. RCHOP-14 for the Treatment of Newly Diagnosed Diffuse Large B Cell Lymphoma: A Prospective Randomized Phase III Clinical Trial from Cswog

Vasculitis Associated with Large Granular Lymphocytes Leukemia

Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation and Failed to Achieve a Complete Response

Neurological Complications Following Allogeneic Haematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only